What is DOCS's five-year median EV/EBITDA?

44.1x. Half of DOCS's weekly readings since May 2022 were higher and half were lower. This page has 231 weekly readings, from May 23, 2022 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares DOCS only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Doximity Inc (DOCS) valuation history

Health Care

$33.39

Latest weekly close · Market cap $6.4B

Below its usual range

As of Oct 24, 2026

DOCS's EV/EBITDA of 29.1x is lower than 81% of its weekly readings since May 2022.

Weekly EV/EBITDA since May 2022

EV/EBITDA each weekMiddle half of its readingsMedian 44.1×

Median: 44.1×
Low to high: 14.8×–69.1×
Versus median: -34%
History starts: May 2022

EV/EBITDA

19thpercentile

of its weekly readings since May 2022

Below its usual range

Growth, last 12 months vs the year before

Revenue: +11%slowing
EPS: -27%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

DOCS EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	33.0×	15
Dec 30, 2024	51.9×	62
Dec 25, 2023	39.6×	24
Dec 26, 2022	56.8×	39

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare DOCS with peers

Health Care peers of DOCS on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
SOLVSolventum	7.7×	Within its usual range	49
VEEVVeeva Systems	42.3×	Below its usual range	20
AAgilent Technologies	26.9×	Historically high	91
ABBVAbbVie	22.6×	Above its usual range	88
ABTAbbott Laboratories	18.9×	Within its usual range	38

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on DOCS

No articles about DOCS yet. How valuation percentiles work

Loading peers and related research…

About this history

What is DOCS's current EV/EBITDA?: DOCS's EV/EBITDA of 29.1x is lower than 81% of its weekly readings since May 2022.
What is DOCS's five-year median EV/EBITDA?: 44.1x. Half of DOCS's weekly readings since May 2022 were higher and half were lower. This page has 231 weekly readings, from May 23, 2022 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares DOCS only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.